Skip to main content

Understand the Science

Live Webinar Series – Understand the Science.

Register and Watch

This unique four-part series is led by, Professor Mark Slevin.

Mark (PhD, FRCPath) is a Professor of Cell Pathology at the Manchester Metropolitan University. He is also a Professor of Pathology at Targu Mures University of Medicine and Pharmacy (Romania) and Weifang University (China). With 280 articles listed in Google Scholar his research interests are focused on cell and tissue regeneration, stem cell biology, and vascular development during healing. He works with scientists and clinicians around the world creating novel therapies to improve the clinical outcome of patients suffering from degenerative disease.

We are honored to be able to present his thoughts and intelligence on these topics. Read more about our series leader – Prof. Mark Slevin

Education is important to us because it is important to you.

‘Understand the Science’ is a live online webinar series that offers the opportunity for something a bit different and a bit deeper.  We will be challenging some of the topics often discussed in our community for injection therapies. 

Over the 4 episodes we’ll cover the topics below and more:

  • The function of endogenous HA in the joint
  • Why HA decreases in OA / during inflammation
  • How exogenous HA effects the negative biology positively
  • When do we intervene with an injection during the OA cycle to effect change? 
  • Can nutrition slow OA, or even prevent the onset?
  • Is endogenous HA sensitive to our nutritional needs
  • Should we use nutritional supplements to promote endogenous HA?
    • What role does the microbiome play in OA and RA
    • The pantheon of injection therapies (mode of action of HA/PRP/MFAT/Hydrogel)
    • Successfully running an injection clinic, what does it look like?
    • Cingal® and Monovisc® – Clinically / Biologically / Pharmacologically
    • What is Rheumatoid Arthritis in practice 
    • The biology of  RA versus OA
    • Injections – HA for RA?  Cingal as a safer, longer-lasting option?


        To achieve such an event,  you need a group of experts with open minds, a wealth of knowledge, and great experience.  Ingredients our speakers bring in abundance.

        Four Key Topics, Four Episodes

        Sign up here

        Ep 1. 7pm, 25th April. The Science of Hyaluronic Acid.

        The science of endogenous HA and what effect does exogenous HA have in an OA joint

        Professor Slevin will kick off the webinar series by giving a detailed understanding of the role Hyaluronic Acid plays in MSK health.

        This will include a closer look at our own native HA, the science of how and why it’s important for joint health, and how can we best utilise exogenous HA to supplement OA and painful joints.

        Sign up

        Ep 2. 7pm 23rd May. Understanding OA Alongside Nutrition

        The OA biology and how nutritional factors such as dietary fats, vitamins, and the microbiome can impact symptoms.

        Prof. Slevin will be joined by Ben Steele-Turner for episode 2 to discuss OA biology and how nutrition can play a positive role.

        Ben is a MSK Physiotherapist, Registered Associate Nutritionist, and Personal Trainer in Horsham, West Sussex. We recommend following Ben on Instagram, he shares some excellent content. @physiutrition

        Sign up

        Ep 3. 7pm 5th June. HA injections Therapies for OA

        The science of Cingal and Monovisc alongside the plethora of MSK injectable options

        Joining Prof Slevin in Ep. 3 is Mr. Bilal Barkatali, an expert joint preservation and soft tissue knee surgeon in Manchester. Bilal will offer exceptional insight and thoughts on injection therapies, explaining the choices he makes for his patients.

        You can find out more about Bilal and his practice at: www.thekneeclinicmanchester.com

        Sign up

        Ep 4. 7pm 25th June. Rheumatoid Arthritis

        The biology of rheumatoid arthritis and how can injection therapies potentially support this autoimmune condition.

        Our expert guest to join Prof. Slevin on this topic is Jack March, a physiotherapist specialising in Rheumatology. With 12 years of experience in the field, he is an extremely respected voice in the healthcare community, sharing his knowledge and expertise on social media while maintaining his dedication as a physiotherapist to rheumatological conditions, supporting his patients to live their best lives.

        Learn more about Jack here: rheumatology.physio

        Sign up

        Turn on, Tune in, or watch again.

        Each episode will be going live at 7 pm, with approximately 45 minutes of presentations + time for Q&A.  Any questions that we don’t get a chance to answer live, we will get back to you after the event is finished.

        Anyone who has registered their interest will be sent the link to watch live and also to watch again in case you missed it.  Please share this information with any colleagues and clinicians who are currently treating OA patients. 

        Contact us if you’d like to find out more about the series, the speakers, Eos Active, and our products. 

        Continue reading

        Synovial Fluid

        Synovial Fluid – Guardian of the Joint

        Synovial fluid is part of the joint. And like any other part of the joint, if it changes, if it’s out of balance or no longer functions as it’s meant to, the cascade of joint disease starts to accelerate.

        It’s basically defined as the collection of fluid confined within a joint space. The healthy synovial fluid within healthy joints functions as a biological lubricant as well as a biochemical carrier, through which nutrients and regulatory cytokines travel. It contains certain molecules that provide low-friction and low-wear properties to articulating cartilage surfaces. Without healthy synovial fluid in our joints, the wear on the cartilage surface will increase.

        What is it?

        Synovial fluid is physiologic and acts as a joint space lubricant. It is the nutrient source for cartilage, meniscus, labrum, etc. It’s produced as an ultrafiltrate of blood plasma, primarily composed of hyaluronan, lubricin, proteinase, collagenases, and prostaglandins, and is produced from fibroblast-like synovial cells.

        A closer look

        A healthy knee for example contains ~2mL of synovial fluid.

        This consists of:

        • Hyaluronic acid: A viscous glycosaminoglycan serves as a structural element and lubricant. HA is in high concentration within the healthy synovial fluid, it is a key component to the extracellular matrix of cartilage, supporting chondrocytes.
        • Lubricin: The most lubricating and anti-adhesive molecule in the human body. It is a surface-active mucinous glycoprotein secreted in the synovial joint and plays an important role in cartilage integrity. Lubricin molecules coat the cartilage surface, providing boundary lubrication and preventing cell and protein adhesion.
        • Proteinase: An enzyme that catalyzes proteolysis, the breakdown of proteins into smaller polypeptides or single amino acids.
        • Collagenases: Enzymes that break the peptide bonds in collagen.
        • Prostaglandins: Produced in nearly all cells and are part of the body’s way of dealing with injury and illness. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response.

        Choosing treatments to match pathology

        Synovial fluid can change and create negative effects in the joint. Volume and content changes occur in response to trauma, inflammation, and bacterial, fungal, or viral penetrance. If a patient presents with acutely painful joints with suspicion of infection, inflammation or non-inflammatory causes of effusion, synovial fluid aspiration and analysis can be a really useful part of the overall analysis when considering direct treatment modality.

        Strategies to maintain healthy synovial fluid

        Synovial fluid can be heavily influenced by our day-to-day life with simple factors coming into play.

        1. Stay Hydrated: It is essential for overall health but this includes joint health. Dehydration can reduce synovial fluid production.
        2. Balanced Diet: Consume a well-balanced diet rich in omega-3 fatty acids, antioxidants, and nutrients like vitamins C and E. These nutrients support joint health and can indirectly contribute to synovial fluid production.
        3. Regular Exercise: Engage in regular, low-impact exercises to stimulate the production of synovial fluid. Activities like swimming, walking, and cycling are beneficial for joint health.”Diet and activity uniquely altered SF metabolites attributed to amino acids, lipids, and steroids. Notably, a high-fat diet increased network connections to systemic biomarkers such as interleukin-1β and glucose intolerance. In contrast, exercise increased local joint-level network connections, especially among subchondral bone features and SF metabolites.” https://doi.org/10.1016/j.joca.2021.08.008
        4. Joint Mobility Exercises: Perform specific exercises that target joint mobility. These exercises help in the distribution of synovial fluid within the joint capsule.
        5. Maintain a Healthy Weight: Extra body weight can put additional stress on the joints, leading to inflammation and reduced synovial fluid production. Maintaining a healthy weight can alleviate this pressure.
        6. Supplements: Some supplements may support joint health. Glucosamine and chondroitin sulfate are commonly used to promote joint lubrication and reduce stiffness. More data is needed but it can seen as part of an overall healthier approach to life. It is always better to support nutritional needs through diet when possible.
        7. Heat Therapy: Applying heat to the affected joint can improve blood circulation and stimulate synovial fluid production. This can be done through warm compresses or hot baths.
        8. Massage and Physiotherapy: Regular massage and physio help to improve joint flexibility, reduce stiffness, and promote synovial fluid circulation.
        9. Avoid Prolonged Immobility: Prolonged periods of immobility can lead to decreased synovial fluid production. Take breaks, stretch, and move regularly throughout the day. A sedentary lifestyle is not a good idea for joint health.
        10. Injection therapies: They can support a patient to increase activity again once the joint disease is present and the synovial fluid is compromised. This helps to halt the painful OA cycle and creates a positive one, allowing patients to be active and motivated to achieve 1-9

        Look after your synovial fluid

        We have excellent surgical strategies in the key areas to repair and preserve the joint. We can also brace a joint to offload pain and manage biomechanics. However, do patients understand the underlying causes of what leads to these issues in the first place? Can we improve our own synovial fluid, in turn improving overall joint health through good lifestyle choices?

        Prevention is better than cure, a healthy active lifestyle, a good diet, good nutrition, staying hydrated, and as soon as you feel joint pain seek advice from a healthcare professional. Non-operative treatments can delay surgical intervention or in some cases prevent them altogether. But before any intervention, look after your body, it’s the only one you’ll get.

        Continue reading

        UK Partners

        Exclusive UK Partnership with Anika and Movianto

        Trusted UK-licensed product, distributed by Movianto.  Leading the way in medical device sales, marketing and logistics.

        Eos Active is part of a unique 3-way partnership with global joint preservation specialists Anika and storage and distribution specialists Movianto.  

        Our role is to support UK customers with the sales, marketing, and education of Anika’s OA pain management portfolio.  The products included in this portfolio are Cingal, Monovisc, and the Orthovisc family.  See below and click the image for more information.

        • Cingal

        • Monovisc

        • Orthovisc

        • Orthovisc Mini

        • Orthovisc T

        Movianto

        Movianto is the leading logistics partner of the healthcare industry in Europe with a network covering 11 countries (see all their locations). They offer an end-to-end distribution strategy: primary transport, storage, order fulfillment, manufacturing, financial services, customs management, last-mile transport.

        That experience, knowledge, and expertise is of course passed through to their UK operation. 

          Movianto in the UK

          • 16 locations including Bedford, Tamworth, Haydock, and Belfast
          • Certifications:​ ISO 9001, ISO 13485, ISO 45001, GDP, GMP, Home Office Controlled Drugs license
          • 96,445m² of warehouse space​
          • 157,932 total pallet spaces ​
          • 1265 employees​ (Dec 2023)
          • 1,138,186 order lines in 2023
          • Bedford Link is the BREEAM-rated “Excellent” headquarters, home to our Medical Device Centre of Excellence, the largest Controlled Drugs Vault in Europe, a GMP re-work facility, and storage capacity for over 90,000 pallets dedicated to healthcare. This site is 25% solar powered with 500 solar panels. 
          • Their Tamworth site is fitted with state-of-the-art automated carton sortation. This is the central point in the network, and the hub and spoke approach removes over 600,000 miles of travel for our fleet, per year.

          Movianto in the UK like the overall international business, prioritises diversity of background, expertise, and culture as a main step to the group’s success. The Movianto international community is made up of over 3,000 teammates. Their people are our most valuable asset and they make sure to support their employees in their development within the group.

          Partnership

          At Eos Active, it is an absolute honor to work alongside and in partnership with two inspiring organisations such as Anika and Movianto.

          Not only is ordering through Eos Active or directly with Movianto the only way in the UK to procure officially approved UK products of the OA pain management options, but we also work closely together to develop this unique three-way partnership to give UK clinicians the very best in product, service, support, and education. 

          Contact us

          Please get in touch to discuss anything about the product options or for more information about any topics covered in this update. 

          Contact us

          #ActiveFreedom

          Continue reading

          Cingal – Chondroprotective

          Cingal – Chondroprotective

          Steroid injections have a place in managing joint pain. How, when, and where always generates great debate.

          A very interesting scientific paper by Bauer et al looks at the ‘increased chondroprotective effect of combining HA with a steroid…’ and adds further discussion to that debate.


          Cingal consists of Triamcinolone Hexacetonide, a ‘kinder’ yet potent steroid that is held in suspension with Hyaluronic Acid. Much more than a simple mixture. This gives a safe and consistent delivery that complies with medical device regulations.

          Practical benefits for a patient include:
          💉 One injection
          🏨 One visit
          💷 One standard cost
          📈 92% response rate – 26 weeks
          📉 72% pain reduction – 26 weeks

          Increased Chondroprotective Effect of Combining Hyaluronic Acid with a Glucocorticoid Compared to Separate Administration on Cytokine-Treated Osteoarthritic Chondrocytes in a 2D Culture

          Abstract;

          Intra-articular injections of glucocorticoids (GC) or hyaluronic acid (HA) are commonly used interventions for patients suffering from knee osteoarthritis (OA). Both substances are combined to achieve a chondroprotective and anti-inflammatory effect. Clinical studies have shown benefits, but data on the cellular level are still lacking. This study aimed to investigate the effect of the GC triamcinolone hexacetonide, HA, and a mix of both substances on cytokine-treated chondrocytes in vitro. Chondrocytes isolated from human articular cartilage were seeded on 6- and 24-well plates. Mimicking OA’s inflammatory state, cells were treated with IL-1β and IL-17 for six days, whereby, after three days, test substances (10%) were added to the culture medium. Chondrocytes were analyzed on days three and six concerning their actin polymerization, expression of anabolic and catabolic genes, metabolic activity, cytokine release, and reactive oxygen species (ROS). Adding HA or GC/HA to the inflammatory culture medium increased the metabolic activity of chondrocytes, while groups containing GC reduced catabolic gene expression and the release of TNF-α. In addition, enhanced F-actin content was shown supplementing HA or GC/HA to the culture medium. Supplementing GC with HA leads to an anti-inflammatory and chondroprotective effect by diminishing the side effects of GC supplementation alone.

          Full paper

          Cingal for Knee Pain

          Cingal offers patients with knee arthritis pain relief within 24-48 hours of receiving the injection.  The above paper scientifically demonstrates that the positive effects of rapid pain relief from the steroid are not diminished, but the potentially harmful effects associated with steroid injections on the chondral surface are.  

          Cingal manages pain with rapid effect while maintaining the chondroprotective properties of a normal Hyaluronic Acid. 

          Find out more

          Cingal

          #ActiveFreedom

          Community @ Eos Active

          Continue reading

          Cingal medical device

          Cingal® – A Medical Device

          Cingal is a next-generation, unique pain management injection therapy, that is classified the same as a Hyaluronic Acid injection, a medical device.   Therefore Cingal does not require a prescription although contains a potent, yet gentler-acting steroidal component to its makeup. 

          So, what’s the deal, why a medical device, what is CINGAL®?

          Cingal ® is a combination of Monovisc (the worlds mot injected HA for joint pain) and Traimcinolone Hexacetinide (TH).  To understand Cingal is to understand TH. 


          TH is a slower-release steroid but works incredibly well to control inflammation and pain in the Osteoarthritic Joint.

          • Fast pain relief, generally beginning 24 hours after administration
          • Approximately 5X the potency of hydrocortisone
          • TH maintains anti-inflammatory levels longer due to its slow release over time
          • Achieves low systemic levels of corticosteroid
          • Well tolerated, associated with fewer flare-ups than TA
          • A safe choice: Pediatric Indication

          TH is active for 10-14 days


          Reducing inflammation to allow HA to work most effectively is backed by strong science, and mixing these two comments is commonly accepted as standard practice for a painful, inflamed OA knee. 

          We know from endogenous HA production and the OA cycle, that inflammation weakens HA.  So to improve the performance of injected HA, it makes sense to manage the inflammation simultaneously.

          The issue is, that steroid doses tend to be higher than is needed (40mg Triamcinolone Acetonide or even double this) and add the further complication that it does not mix with well HA. They separate and do not disperse into the joint evenly.

          Steroid and HA do not naturally mix

          How Corticosteroids works within the joint

          They have an anti-inflammatory and immunosuppressive effect.

          Decrease the local inflammatory modulator response by switching off multiple inflammatory genes by

          1) Interfering with inflammatory cell adhesion

          2) Interrupting cytokines (like IL-1)

          3) impairing leukotriene and prostaglandin synthesis

          The effect of cortisone with knee intra-articular injections

          ↑ vasoconstriction leads to ↓erythema, swelling, heat, tenderness, and pain.

          ↑ relative viscosity & HA concentration, leading to increased mobility. Lower doses (12-18mgs for TH) actually show a possible protective effect on chondral tissue.

          Medical Device Classification and Guidance 

          Cingal®.  TH + Monovisc in a single injection as a medical device.

          It does not require a prescription. Cingal is the safest way to combine steroid with HA.  The TH and HA are micronised, ensuring it is part of the overall injection with no separation. TH is also a slower absorbing steroid meaning it produces a powerful anti-inflammatory effect that continues to work at the more optimum level for longer,  with a gentler action when compared to TA or other corticosteroids commonly used.

          18mg of a slower release, kinder steroid component, combined with 88mg of Hyaluronic Acid, manufactured as a singular product into a syringe that is designed ergonomically, is a very different option to 40mg Ostenil Plus + 40mg TA/Kenelog mixed in a clinic 

          Hence the medical device regulations deaming Cingal a medical device.

          Highlighted in the factsheet for healthcare professionals and health institutions;

          ‘In-house devices –

          The Regulations allow health institutions under certain conditions to manufacture, modify, and use devices ‘on a non-industrial scale’ when equivalent ones are not available commercially……

          Full MDR factsheet

          CINGAL is a MEDICAL DEVICE.

          PROVEN with unmatched clinical data across three Phase III clinical trials. FASTER acting with 59% pain reduction in week 1. LONGER lasting with 72% pain reduction at 26 weeks. CONSISTENT pain reduction results with a 92% responder rate at 26 weeks

          Community @ Eos Active

          #ActiveFreedom

          Continue reading